Hey guys, sorry to see what's happened here. Owned DCTH a long time ago and have always believed in the product. I'm looking at reentering a position at these levels, but wondering everyones thoughts on viability moving forward if they forgo US and focus on other parts of the world. $35m market cap is really low and NAZ delisting or RS won't be for a while. There use to be buyout rumors--a possiblity down here? Did FDA only make prelim decision based on gen 1 filter? Are they considering gen 2 for sept decision or will they delay? Seems like it should be worth more based on non-US potential. What am I missing?
The positive thing about buying now at this stage is the sentiment is pretty damn low as it is, so it's less likely to get clobbered on some bad news. When people are all assuming the worst and ready to throw in the towel, that's when you buy. Imo after 2 nasty gap downs and 75% haircut in price, I think lots of people have thrown in the towel and there should be some upside coming thanks to a lack of supply now. All imo.